The European Union has approved the use of remdesivir to treat severe cases of Coronavirus.
The announcement was made on Friday July 3, days after the US effectively stockpiled the world’s entire supply of the antiviral medication. Its approval came after two major US studies showed that remdesivir can reduce the duration of hospital stay for coronavirus patients.
WHO Clears Air On ‘Approved Vaccine’ For Coronavirus
EU Health Commissioner Stella Kyriakides said in a statement;
“Today’s authorisation of the first medicine to treat COVID-19 is an important step forward in the fight against this virus.
“We are granting this authorisation less than a month after the application was submitted, showing clearly the EU’s determination to respond quickly whenever new treatments become available.”
Research Gives Hope, As Hiv Can Be Prevented After Unprotected Sex
Remdesivir which is the only anti-coronavirus medication to be given the green light in the EU, was originally intended as a treatment for Ebola. It was approved in UK at the end of May, with health officials outlining that it would only be used to treat the sickest patients. It is one of two drugs approved in Britain to treat coronavirus, the other being a cheap steroid called dexamethasone.
Post Disclaimer
The opinions, beliefs and viewpoints expressed by the author and forum participants on this website do not necessarily reflect the opinions, beliefs and viewpoints of Anaedo Online or official policies of the Anaedo Online.